| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |